ERA, Congress

ERA Congress: Long-term data show sustained efficacy and safety of zigakibart in patients with IgA nephropathy

Published on 08/07/2025 at 18:06 | prnewswire.co.uk

ERA Congress United Kingdom United States of America France Germany Spain Austria

en | boerse | 67959206 |